Acute Myeloid Leukemia remains a difficult to treat disease. Leukemic stem cells are instrumental for disease pathogenesis.

Stemness features also play a crucial role for therapy resistance and relapse.

Novel approaches to target leukemic stem cells and to overcome therapy resistance connect basic science and clinicians.

In this workshop, we are going to discuss the most recent developments in the translation of basic concepts into clinical applications for and treatment of AML.